SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $728,383 | -31.3% | 50,177 | -1.0% | 0.00% | – |
Q2 2023 | $1,060,879 | +73.2% | 50,687 | +74.7% | 0.00% | – |
Q1 2023 | $612,648 | +13.2% | 29,008 | +36.4% | 0.00% | – |
Q4 2022 | $541,067 | +17.1% | 21,260 | +10.6% | 0.00% | – |
Q3 2022 | $462,000 | +37.5% | 19,216 | +10.0% | 0.00% | – |
Q2 2022 | $336,000 | +44.8% | 17,472 | +30.7% | 0.00% | – |
Q1 2022 | $232,000 | -15.0% | 13,365 | +7.0% | 0.00% | – |
Q4 2021 | $273,000 | +14.2% | 12,493 | 0.0% | 0.00% | – |
Q3 2021 | $239,000 | +174.7% | 12,493 | +147.7% | 0.00% | – |
Q2 2021 | $87,000 | -29.8% | 5,043 | -8.9% | 0.00% | – |
Q1 2021 | $124,000 | +34.8% | 5,535 | +34.1% | 0.00% | – |
Q4 2020 | $92,000 | +87.8% | 4,129 | +24.3% | 0.00% | – |
Q3 2020 | $49,000 | -25.8% | 3,322 | -25.3% | 0.00% | – |
Q2 2020 | $66,000 | +61.0% | 4,446 | +18.7% | 0.00% | – |
Q1 2020 | $41,000 | +7.9% | 3,747 | -12.9% | 0.00% | – |
Q4 2019 | $38,000 | +46.2% | 4,300 | +22.4% | 0.00% | – |
Q3 2019 | $26,000 | -21.2% | 3,513 | 0.0% | 0.00% | – |
Q2 2019 | $33,000 | +153.8% | 3,513 | +37.0% | 0.00% | – |
Q1 2019 | $13,000 | +18.2% | 2,565 | 0.0% | 0.00% | – |
Q4 2018 | $11,000 | -47.6% | 2,565 | 0.0% | 0.00% | – |
Q3 2018 | $21,000 | +16.7% | 2,565 | 0.0% | 0.00% | – |
Q2 2018 | $18,000 | -45.5% | 2,565 | +10.8% | 0.00% | – |
Q1 2018 | $33,000 | +65.0% | 2,315 | 0.0% | 0.00% | – |
Q4 2017 | $20,000 | -25.9% | 2,315 | 0.0% | 0.00% | – |
Q3 2017 | $27,000 | +80.0% | 2,315 | +109.1% | 0.00% | – |
Q2 2017 | $15,000 | 0.0% | 1,107 | 0.0% | 0.00% | – |
Q1 2017 | $15,000 | +87.5% | 1,107 | 0.0% | 0.00% | – |
Q4 2016 | $8,000 | – | 1,107 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |